Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, California, 92037, USA; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California, 92037, USA.
Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, California, 92037, USA.
DNA Repair (Amst). 2019 Feb;74:80-90. doi: 10.1016/j.dnarep.2018.12.001. Epub 2018 Dec 10.
The DNA double strand breaks (DSBs) created during meiotic recombination and during some types of chemotherapy contain protein covalently attached to their 5' termini. Removal of the end-blocking protein is a prerequisite to DSB processing by non-homologous end-joining or homologous recombination. One mechanism for removing the protein involves CtIP-stimulated Mre11-catalyzed nicking of the protein-linked strand distal to the DSB terminus, releasing the end-blocking protein while it remains covalently attached to an oligonucleotide. Much of what is known about this repair process has recently been deciphered through in vitro reconstitution studies. We present here a novel model system based on adenovirus (Ad), which contains the Ad terminal protein covalently linked to the 5' terminus of its dsDNA genome, for studying the repair of 5' protein-linked DSBs in vivo. It was previously shown that the genome of Ad mutants that lack early region 4 (E4) can be joined into concatemers in vivo, suggesting that the Ad terminal protein had been removed from the genome termini prior to ligation. Here we show that during infection with the E4-deleted Ad mutant dl1004, the Ad terminal protein is removed in a manner that recapitulates removal of end-blocking proteins from cellular DSBs. In addition to displaying a dependence on CtIP, and Mre11 acting as the endonuclease, the protein-linked oligonucleotides that are released from the viral genome are similar in size to the oligos that remain attached to Spo11 and Top2 after they are removed from the 5' termini of DSBs during meiotic recombination and etoposide chemotherapy, respectively. The single nucleotide resolution that is possible with this assay, combined with the single sequence context in which the lesion is presented, make it a useful tool for further refining our mechanistic understanding of how blocking proteins are removed from the 5' termini of DSBs.
DNA 双链断裂(DSBs)在减数分裂重组和某些类型的化疗过程中产生,这些断裂处含有共价连接到其 5' 末端的蛋白质。去除末端阻断蛋白是通过非同源末端连接或同源重组处理 DSB 的前提。去除该蛋白的一种机制涉及 CtIP 刺激的 Mre11 催化的对 DSB 末端远端的蛋白连接链的切口,释放末端阻断蛋白,同时保持其共价连接到寡核苷酸上。最近,通过体外重构研究揭示了许多有关该修复过程的信息。我们在此提出了一种新的基于腺病毒(Ad)的模型系统,该系统包含与 Ad 双链 DNA 基因组 5' 末端共价连接的 Ad 末端蛋白,用于研究体内 5' 蛋白连接 DSB 的修复。先前的研究表明,缺乏早期区域 4(E4)的 Ad 突变体的基因组可以在体内连接成串联体,这表明 Ad 末端蛋白在连接之前已从基因组末端去除。在这里,我们表明在感染缺乏 E4 的 Ad 突变体 dl1004 时,Ad 末端蛋白以类似于从细胞 DSB 中去除末端阻断蛋白的方式被去除。除了显示对 CtIP 的依赖性和 Mre11 作为内切核酸酶的作用外,从病毒基因组释放的蛋白连接寡核苷酸的大小与 Spo11 和 Top2 分别从减数分裂重组和依托泊苷化疗过程中 DSB 的 5' 末端去除后仍附着的寡核苷酸相似。该测定具有单核苷酸分辨率,并且病变呈现的单序列上下文,使其成为进一步完善我们对如何从 DSB 的 5' 末端去除阻断蛋白的机制理解的有用工具。